AAAAAA

   
Results: 1-7 |
Results: 7
RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
Authors: LEMMEL EM REID DM NUKI G AVOUAC B BARDIN T BOUVENOT G CAUWENBERGE H CLUZEL M DEVOLGELAER JP DUFF GW EMERY P ETHGEN D KREUTZ G MENKES CJ REIDEL H SERNI U VANDERAUWERA P VEYS E WHITEGUAY B REGINSTER JY
Citation: Em. Lemmel et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, British journal of rheumatology, 37(2), 1998, pp. 211-215
RISEDRONATE REDUCES THE INCIDENCE OF VERTEBRAL FRACTURES IN PATIENTS ON CHRONIC CORTICOSTEROID-THERAPY
Authors: REID D COHEN S PACK S CHINES A ETHGEN D
Citation: D. Reid et al., RISEDRONATE REDUCES THE INCIDENCE OF VERTEBRAL FRACTURES IN PATIENTS ON CHRONIC CORTICOSTEROID-THERAPY, Arthritis and rheumatism, 41(9), 1998, pp. 624-624
INTERMITTENT CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION AND TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
Authors: ADACHI J ROUX C MONIZ C GEUSENS P DEQUEKER J WEBBER D PACK S ETHGEN D
Citation: J. Adachi et al., INTERMITTENT CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION AND TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, Arthritis and rheumatism, 40(9), 1997, pp. 628-628
A SAFETY REVIEW OF THE USE OF RISEDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE
Authors: SINGER FR BROWN JP SIRIS ES HOSKINGS DJ MILLER PD ETHGEN D AXELROD DW
Citation: Fr. Singer et al., A SAFETY REVIEW OF THE USE OF RISEDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE, Arthritis and rheumatism, 40(9), 1997, pp. 1489-1489
RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS
Authors: DOUGADOS M DEVOGELAER JP ANNEFELDT M AVOUAC B BOUVENOT G COOPER C DIEPPE P ETHGEN D GARATTINI S JONES EA KAUFMAN JM LEEMING M LEMMEL EM LOHMANDER S MENKES CJ NUKI G PAOLOZZI L PUJOL JP ROVATI L SERNI U SPECTOR T TSOUDEROS Y VEYS EM WESELOH G REGINSTER JY
Citation: M. Dougados et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS, Annals of the Rheumatic Diseases, 55(8), 1996, pp. 552-557
EFFICACY AND TOLERABILITY OF A NEW FORMULATION OF ORAL TILUDRONATE (TABLET) IN THE TREATMENT OF PAGETS-DISEASE OF BONE
Authors: REGINSTER JY TREVES R RENIER JC AMOR B SANY J ETHGEN D PICOT C FRANCHIMONT P
Citation: Jy. Reginster et al., EFFICACY AND TOLERABILITY OF A NEW FORMULATION OF ORAL TILUDRONATE (TABLET) IN THE TREATMENT OF PAGETS-DISEASE OF BONE, Journal of bone and mineral research, 9(5), 1994, pp. 615-619
EVIDENCE THAT TILUDRONATE IS AN INTERESTING PERSPECTIVE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Authors: REGINSTER JY ETHGEN D BARBIER A GEUSENS P LECART MP CHAPPARD D DEVERNEJOUL MC ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., EVIDENCE THAT TILUDRONATE IS AN INTERESTING PERSPECTIVE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 8, 1993, pp. 190000326-190000326
Risultati: 1-7 |